Radjabu Bigirimana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Radjabu Bigirimana has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Berthe Barhayiga
University of Kinshasa
1 shared publication - Claude Mambo Muvunyi
Department of Biomedical Services, Rwanda Biomedical Centre, Kigali, Rwanda
1 shared publication - Etienne Bwira Mwokozi
University of Kinshasa
1 shared publication - Godefroid Musema M.A
Ecole de Santé Publique de Kinshasa
1 shared publication - Jack Kokolomami
University of Kinshasa
1 shared publication - Jean C. Mugisha
Africa Centres for Disease Control and Prevention
1 shared publication
Latest Publications
- Open Access
- 30 June 2025
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 16 (1) , 4
Leveraging risk communication and community engagement and lessons from previous outbreaks to strengthen a Public Health response: A case study of Disease X in the Panzi region, DRC
On 08 December 2024, the World Health Organization (WHO) reported an outbreak of Disease X in the Panzi Health Zone, Kwango province, Democratic Republic of the Congo (DRC). This unknown pathogen, with 406 cases and 31 deaths at the time of its declaration, predominantly affects children under 5 years. Disease X, hypothesised to be a zoonotic ribonucleic acid (RNA) virus, poses significant challenges because of limited healthcare infrastructure, gaps in risk communication and ineffective community engagement. This opinion article aims to explore these challenges and advocate for the urgent need for culturally tailored, inclusive communication strategies that foster trust and empower local communities in responding to outbreaks. Key approaches highlighted include mobilising local leaders, utilising mobile laboratories for decentralised diagnostics and improving sample collection techniques. Drawing on lessons from previous epidemics, such as COVID-19 and Ebola, this article emphasises the importance of robust
- 30 June 2025
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 16 (1) , 4
Open AccessLeveraging risk communication and community engagement and lessons from previous outbreaks to strengthen a Public Health response: A case study of Disease X in the Panzi region, DRC
On 08 December 2024, the World Health Organization (WHO) reported an outbreak of Disease X in the Panzi Health Zone, Kwango province, Democratic Republic of the Congo (DRC). This unknown pathogen, with 406 cases and 31 deaths at the time of its declaration, predominantly affects children under 5 years. Disease X, hypothesised to be a zoonotic ribonucleic acid (RNA) virus, poses significant challenges because of limited healthcare infrastructure, gaps in risk communication and ineffective community engagement. This opinion article aims to explore these challenges and advocate for the urgent need for culturally tailored, inclusive communication strategies that foster trust and empower local communities in responding to outbreaks. Key approaches highlighted include mobilising local leaders, utilising mobile laboratories for decentralised diagnostics and improving sample collection techniques. Drawing on lessons from previous epidemics, such as COVID-19 and Ebola, this article emphasises the importance of robust
- Open Access
- 11 February 2025
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 16 (4)
Bayesian predictive model of Ebola fatality: Tenth Ebola epidemic in the Democratic Republic of the Congo
Background: This study aimed to identify the clinical signs and symptoms most associated with fatal outcomes in Ebola virus disease (EVD) using a Bayesian framework. Aim: The goal was to develop a prognostic model capable of predicting mortality in EVD patients treated in Ebola Treatment Centres (ETCs) based on observed clinical indicators. Setting: A retrospective expert-based study of the 10th Ebola outbreak was conducted to identify key mortality factors using hypothetical cases in the Democratic Republic of the Congo. Methods: Clinical experts assessed mortality predictors in Ebola cases using Bayesian methods to estimate likelihood ratios and post-test probabilities, with analyses conducted in Excel and SPSS. Results: Eight clinical factors were identified as potential predictors of poor outcomes in Ebola virus disease. Five showed strong associations with mortality: deterioration in general condition and comorbidity, hemorrhagic syndrome, neurological disorders, biological deterioration with dehydration, and high viral load at diagnosis. Internal validation using 42 hypothetical cases demonstrated excellent performance (sensitivity [Se] = 97.4%, specificity [Sp] = 100.0%, positive predictive value [PPV] = 100.0%, negative predictive value [NPV] = 75.0%, accuracy = 97.6%) and strong expert agreement (κ = 0.84). Conclusion: The model demonstrated strong internal validity in predicting mortality from Ebola virus disease. Among five key predictors, bleeding syndrome, neurological disorders, and biological alteration with dehydration were the most accurate, each correctly predicting fatal outcomes in 83% of cases. Contribution: This Bayesian model offers a useful decision-support tool for managing Ebola outbreaks.
- 11 February 2025
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 16 (4)
Open AccessBayesian predictive model of Ebola fatality: Tenth Ebola epidemic in the Democratic Republic of the Congo
Background: This study aimed to identify the clinical signs and symptoms most associated with fatal outcomes in Ebola virus disease (EVD) using a Bayesian framework. Aim: The goal was to develop a prognostic model capable of predicting mortality in EVD patients treated in Ebola Treatment Centres (ETCs) based on observed clinical indicators. Setting: A retrospective expert-based study of the 10th Ebola outbreak was conducted to identify key mortality factors using hypothetical cases in the Democratic Republic of the Congo. Methods: Clinical experts assessed mortality predictors in Ebola cases using Bayesian methods to estimate likelihood ratios and post-test probabilities, with analyses conducted in Excel and SPSS. Results: Eight clinical factors were identified as potential predictors of poor outcomes in Ebola virus disease. Five showed strong associations with mortality: deterioration in general condition and comorbidity, hemorrhagic syndrome, neurological disorders, biological deterioration with dehydration, and high viral load at diagnosis. Internal validation using 42 hypothetical cases demonstrated excellent performance (sensitivity [Se] = 97.4%, specificity [Sp] = 100.0%, positive predictive value [PPV] = 100.0%, negative predictive value [NPV] = 75.0%, accuracy = 97.6%) and strong expert agreement (κ = 0.84). Conclusion: The model demonstrated strong internal validity in predicting mortality from Ebola virus disease. Among five key predictors, bleeding syndrome, neurological disorders, and biological alteration with dehydration were the most accurate, each correctly predicting fatal outcomes in 83% of cases. Contribution: This Bayesian model offers a useful decision-support tool for managing Ebola outbreaks.